← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Oklahoma State University Stillwater
Stillwater, OK
$150,483,401
Total funding
205
Grants
Funding over time
peak $15.6M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$148,363,212 · 199
FDA$1,091,686 · 4
CDC$1,028,503 · 1
SAMHSA$0 · 1
By mechanism
R01$64,320,165 · 47
P20$26,844,350 · 29
R15$20,700,493 · 43
R21$10,908,728 · 27
R37$5,957,656 · 2
R35$5,263,453 · 4
Investigators at Oklahoma State University Stillwater
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
Oklahoma Center for Respiratory and Infectious Diseases$2,476,566
P20 · FY2013 · GM
Oklahoma Center for Microbiome Research$2,381,601
P20 · FY2024 · GM
Oklahoma Center for Respiratory and Infectious Diseases$2,236,246
P20 · FY2022 · GM
Oklahoma Center for Respiratory and Infectious Diseases$2,233,766
P20 · FY2021 · GM
Oklahoma Center for Respiratory and Infectious Diseases$2,233,269
P20 · FY2020 · GM
Oklahoma Center for Respiratory and Infectious Diseases$2,209,879
P20 · FY2019 · GM
Oklahoma Center for Respiratory and Infectious Diseases$2,205,488
P20 · FY2018 · GM
Oklahoma Center for Respiratory and Infectious Diseases$2,188,662
P20 · FY2014 · GM
Oklahoma Center for Respiratory and Infectious Diseases$2,185,103
P20 · FY2015 · GM
Oklahoma Center for Respiratory and Infectious Diseases$2,181,997
P20 · FY2016 · GM
Oklahoma Center for Respiratory and Infectious Diseases$2,178,933
P20 · FY2017 · GM
Oklahoma Center for Microbiome Research$2,132,840
P20 · FY2025 · GM
Administrative Core$1,193,379
P20 · FY2021 · GM
The role of FENDRR in host defense against Mycobacterium tuberculosis infection$1,192,312
R01 · FY2025 · AI
Oklahoma Center for Respiratory and Infectious Diseases$1,101,147
P30 · FY2023 · GM
Oklahoma Center for Respiratory and Infectious Diseases$1,098,507
P30 · FY2025 · GM
Oklahoma Center for Respiratory and Infectious Diseases$1,088,733
P30 · FY2024 · GM
Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis$915,887
R01 · FY2011 · AI
Administrative Core$911,621
P20 · FY2020 · GM
Administrative Core$898,050
P20 · FY2022 · GM